BCL2L11 and acute myeloid leukemia: Combined treatment with venetoclax and the selective MCL-1 inhibitor A-1210477 abrogates MCL-1 sequestration of Bim and results in synergistically induced apoptosis in AML cell lines and primary patient samples (39).